Journals / Turkish Journal of Gastroenterology / 2005 / Cilt: 16 - Sayı: 4

Orak hücre hastalığında karaciğer tutulumu

Liver involvement in sickle cell disease

Pages
194–198
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our data suggest that chronic liver injury in patients with sickle cell disease seems to be a multifactorial phenomenon depending mostly on overlapping factors such as iron overload and viral damage rather than primary disease itself.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: Liver involvement in sickle cell disease may take place due to the primary disease itself or to secondary conditions such as iron overload, viral hepatitis and cholelithiasis.
📊
Key Findings & Data:In the present study we have tried to evaluate the frequency of hepatic dysfunction and etiological factors in 48 patients with sickle cell disease.
💡
Conclusion & Impact:Conclusion: Our data suggest that chronic liver injury in patients with sickle cell disease seems to be a multifactorial phenomenon depending mostly on overlapping factors such as iron overload and viral damage rather than primary disease itself.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anemi · orak hücreli · Karaciğer fonksiyon testleri

Abstract

Background/aims: Liver involvement in sickle cell disease may take place due to the primary disease itself or to secondary conditions such as iron overload, viral hepatitis and cholelithiasis. In the present study we have tried to evaluate the frequency of hepatic dysfunction and etiological factors in 48 patients with sickle cell disease. Methods: Clinical and laboratory investigation including liver function tests, serological tests for viral hepatitis, and abdominal ultrasonography were performed in all of the patients. Additionally, liver biopsies were taken from 13 patients. Results: Intrasinusoidal sickling and Kupffer cell hyperplasia were consistently seen in all of the biopsy specimens. Hepatomegaly was present in all patients, whereas liver function test abnormalities were seen in 27%. The prevalence of cholelithiasis was found as 35%. Serological tests demonstrated the presence of hepatitis B surface antigen in three, antibody to hepatitis B virus in 19 and antibody to hepatitis C virus in four of the patients. The most significant contributory finding was the presence of hemosiderosis in histological examination of liver specimens. Conclusion: Our data suggest that chronic liver injury in patients with sickle cell disease seems to be a multifactorial phenomenon depending mostly on overlapping factors such as iron overload and viral damage rather than primary disease itself.

Özet

Amaç: Orak hücre hastalığında karaciğer tutulumu primer hastalık ya da aşırı demir yüklenmesi, viral hepatitler ve kolelithiasis nedeniyle gelişebilir. Çalışmamızda 48 orak hücre hastasında hepatik disfonksiyon sıklığını ve etyolojik faktörleri inceledik. Yöntem: Tüm hastalarda klinik bulgularla birlikte esas olarak karaciğer fonksiyon testleri olmak üzere laboratuar bulgular incelendi ve üst batın ultrasonografisi yapıldı. Ek olarak 13 hastadan karaciğer biyopsisi alındı. Bulgular: Biyopsi örneklerinin tümünde intrasinüzoidal oraklaşma ve Kupffer hücre hiperplazisi izlendi. Tüm hasta grubunda hepatomegali, %27 hastada ise karaciğer fonksiyon testlerinde bozukluk mevcuttu. Kolelithiasis sıklığı 35% olarak bulundu. Serolojik test sonuçlarına gore hepatit B yüzey antijeni üç, hepatit B antikor pozitişiği 19 ve hepatit C antikor pozitişiği ise toplam dört hastada tespit edildi. Karaciğer örneklerinin histolojik incelemesinde en sık izlenen bulgu hemosiderosis idi. Sonuç: Bulguları mız orak hücre hastalarında kronik karaciğer hasarının genellikle birden fazla nedeni olduğunu, bu faktörler arasında ise primer hastalıktan çok aşırı demir yükünün ve viral nedenlerin ön planda olduğunu düşündürmektedir.

🔖

Cite This Article

GÜRKAN, E., ERGÜN, Y., ZORLUDEMİR, S., BAŞLAMIŞLI, F., KOÇAK, R. (2005). Orak hücre hastalığında karaciğer tutulumu. Turkish Journal of Gastroenterology, Cilt: 16 - Sayı: 4, 194–198. https://ajindex.com/articles/411196

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Kakarala S, Lindberg M. Safety of liver biopsy in acute sickle hepatic crisis. Conn Med 2004; 68(5): 277-9
  2. Beutler E. The sickle cell diseases and related disorders. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. New York: McGraw Hill, 1999; 581-605
  3. Alt›ntafl E, Tiftik EN, Üçbilek E, et al. Sickle cell anemia connected with chronic intrahepatic cholestasis: a case report. Turk J Gastroenterol 2003; 14(3): 215-8
  4. Bauer TW, Moore GW, Hutchins GM. The liver in sickle cell disease. A clinicopathologic study of 70 patients. Am J Med 1980; 69(6): 833-7
  5. Rosenblate HJ, Eisenstein R, Holmes AW. The liver in sickle cell anemia. A clinical-pathologic study. Arch Pathol 1970; 90(3): 235-45
  6. Omata M, Johnson CS, Tong M, et al. Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci 1986; 31(3): 247-56
  7. Schubert TT. Hepatobiliary system in sickle cell disease. Gastroenterology 1986; 90(6): 2013-21
  8. Serjeant GR. Sickle Cell Disease. Oxford, England: Oxford University Press, 1985; 100
  9. Braun B, Günther R, Schwerk W. Ultraschall diagnostik, Lehrbuch und Atlas. Verlag Mayer, 1986: 9-29
  10. Gladisch R. Praxis der abdaminalen ultraschal-diagnostik. Schatlauer Verlag, 1982: 74-109
  11. Green TW, Conley Cl, Berthrong M. The liver in sickle cell anemia. Bull Johns Hopkins Hosp 1953; 92(2): 99-127
  12. Hassan M, Hasan S, Giday S, et al. Hepatitis C virus in sickle cell disease. J Natl Med Assoc 2003; 95(10): 939-42
  13. Hassan M, Hasan S, Castro O, et al. HCV in sickle cell disease. J Natl Med Assoc 2003; 95(9): 864-7
  14. Ballas SK, Lewis CN, Noone AM, et al. Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol 1982; 13(1): 37-51. 15 Phillips JC, Gerald BE. The incidence of cholelithiasis in sickle cell disease. Am J Roentgenol Radium Ther Nucl Med 1971; 113(1): 27-8
  15. Johnson CS, Omata M, Tong MJ, et al. Liver involvement in sickle cell disease. Medicine (Baltimore) 1985; 64(5):349-56
  16. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 1975; 68(3): 525-33
  17. Olivieri NF. Progression of iron overload in sickle cell disease. Semin Hematol 2001; 38 (1 Suppl 1): 57-62
  18. Charlotte F, Bachir D, Nenert M, et al. Vascular lesions of the liver in sickle cell disease. A clinicopathological study in 26 living patients. Arch Pathol Lab Med 1995; 119(1):46-52
  19. Teixeira AL,